Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-15T00:10:41.743Z Has data issue: false hasContentIssue false

Serotonergic mechanisms and the new antidepressants

Published online by Cambridge University Press:  09 July 2009

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © Cambridge University Press 1993

References

Åsberg, M., Schalling, D., Traskman-Bendz, L. & Wagner, A. (1987). Psychobiology of suicide, impulsivity, and related phenomena. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H.), pp. 655668. Raven Press: New York.Google Scholar
Beasley, C. M. Jr., Dornseif, B. E., Bosomworth, J. C., Sayler, M. E., Rampey, A. H. Jr., Heiligenstein, J. H., Thompson, V. L., Murphy, D. J. & Masica, D. N. (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 303, 685692.CrossRefGoogle ScholarPubMed
Brown, G., Goodwin, F., Ballenger, J., Goyer, P. & Major, L. (1979). Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatry Research 1, 131139.CrossRefGoogle Scholar
Eisen, M. S. (1980). Azapirones: mechanism of action in anxiety and depression. Drug Therapy supplement 1, 38.Google Scholar
Enna, S. J., Malick, J. B. & Richelson, E. (1981). Antidepressants: Neurochemical, Behavioural and Clinical Perspectives. Raven Press: New York.Google Scholar
Fagius, J., Osterman, P. O., Siden, A. & Wiholm, B.-E. (1985). Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery and Psychiatry 48, 6569.CrossRefGoogle ScholarPubMed
Feighner, J. P. & Boyer, W. F. (1991). Selective Serotonin Reuptake Inhibitors. Wiley: New York.Google Scholar
Grahame-Smith, D. G. (1992). An overview of serotonin and psychiatry. In Serotonin 1A Receptors in Anxiety and Depression (ed. Stahl, S. M., Gastpar, M., Hesselink, J. Keppel and Traber, J.), pp. 121. Raven Press: New York.Google Scholar
Hartig, P., Kao, H.-T., Macchi, M., Adham, N., Zgombick, J., Weinshank, R. & Brancheck, T. (1990). The molecular biology of serotonin receptors: an overview. Neuropsychopharmacology 3, 335347.Google ScholarPubMed
Leysen, J. E. (1990). Gaps and peculiarities in 5HT2 receptor studies. Neuropsychopharmacology 3, 361369.Google ScholarPubMed
Martin, G. (1990). Current problems and future requirements for 5-hydroxytryptamine classification. Neuropsychopharmacology 3, 321333.Google ScholarPubMed
Roy, A. & Linnoila, M. (1990). Monoamines and suicidal behavior. In Violence and Suicidality: Perspective in Clinical and Psychobiological Research (ed. van Praag, H., Plutchik, R. and Apter, A.), pp. 141183. Brunner: Bazel.Google Scholar
Stahl, S. M. (1992). Serotonin neuroscience discoveries usher in a new era of novel drug therapies for psychiatry. Psychopharmacology Bulletin 28, 39.Google Scholar
Stahl, S. M., Gastpar, M., Keppel Hesselink, J. & Traber, J. (eds.) (1992). Serotonin 1A Receptors in Anxiety and Depression. Raven Press: New York.Google Scholar
Teicher, M. H., Glod, C. & Cole, J. O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry 147, 207210.Google ScholarPubMed
Virkkunen, M., Nuutila, A., Goodwin, F. & Linnoila, M. (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry 44, 241247CrossRefGoogle ScholarPubMed